| 0.2 |
1.2 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
0.6 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 |
0.9 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.6 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 0.1 |
0.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.8 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.5 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.3 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
0.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
1.3 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.2 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 |
1.4 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
2.6 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.9 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
0.2 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 |
0.6 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.3 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.2 |
GO:0070428 |
granuloma formation(GO:0002432) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.1 |
0.3 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.3 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.3 |
GO:1901077 |
regulation of relaxation of muscle(GO:1901077) |
| 0.0 |
0.1 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.0 |
0.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 |
0.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.0 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) alditol biosynthetic process(GO:0019401) |
| 0.0 |
0.2 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.0 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.0 |
0.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.3 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.3 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.7 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 |
1.3 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.1 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.0 |
0.6 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.0 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 0.0 |
1.1 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
0.4 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.2 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.0 |
0.5 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.2 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.0 |
0.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.7 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.0 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.0 |
1.0 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
